$MRNS News Article - Marinus Pharmaceuticals Announces European Commission Approval of ZTALMY (ganaxolone) for the Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficiency Disorder
https://marketwirenews.com/news-releases/mari...39534.html